Frusidale 40Mg

Target species Cats and dogs. Indications for use For the treatment of oedema associated with cardiac insufficiency, renal dysfunction and trauma in cats and dogs. In animals with pulmonary oedema of cardiac origin, combined therapy with other medicinal products may be indicated. Contraindications Do not use in animals with acute glomerular nephritis, renal failure with anuria, electrolyte deficiency disease or in animals that have received an overdosage of digitalis. Do not use concurrently with aminoglycoside antibiotics. Do not use in animals weighing less than 4 kg. Special precautions for use in animals Do not exceed the recommended dosage. Therapeutic efficacy may be impaired by increased intake of drinking water. Where the animal's condition permits, water intake should be restricted during treatment with Frusedale 40 mg oral tablets. Monitoring of plasma potassium levels is advisable during periods of prolonged treatment of combined therapy with cardiac glycosides. Potassium supplements may be necessary. Special precautions to be taken by the person administering the veterinary medicinal product to animals Wear gloves, or wash your hands immediately after handling the tablets. Adverse reactions Administration at the recommended dosage level is not normally associated with undesirable effects. Use during pregnancy and lactation Frusedale 40 mg oral tablets are not contraindicated in pregnant or lactating animals. Interactions Concurrent administration with corticosteroids may increase the risk of hypokalaemia. Concurrent administration with aminoglycoside antibiotics may result in ototoxicity. Concurrent administration with cephalosporin antibiotics may result in nephrotoxicity. Concurrent administration with digoxin enhances the cardiac glycoside. Concurrent administration with sulphonamide antibacterials may result in sulphonamide allergy.
Vat Rate: 20%